Paper464451
Racemic warfarin and trimethoprim-sulfamethoxazole interaction in humans.
O'Reilly RA and 1 other. Ann Intern Med, 1979. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Racemic warfarin and trimethoprim-sulfamethoxazole interaction in humans. Papers, record 464451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/464451
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sulfamethoxazole | Major topic |
| Trimethoprim | Major topic |
| Warfarin | Major topic |
| Adult | |
| Drug Combinations | |
| Drug Interactions | |
| Humans | |
| Male | |
| Prospective Studies | |
| Prothrombin Time |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31127283 | Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients. | J Antimicrob Chemother | 2019 | https://conductscience.org/library/papers/31127283 | PubMed |
| 16050864 | The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. | J Gen Intern Med | 2005 | https://conductscience.org/library/papers/16050864 | PubMed |
| 10709776 | Effects of the antifungal agents on oxidative drug metabolism: clinical relevance. | Clin Pharmacokinet | 2000 | https://conductscience.org/library/papers/10709776 | PubMed |
| 8452656 | Stereoisomers and drug toxicity. The value of single stereoisomer therapy. | Drug Saf | 1993 | https://conductscience.org/library/papers/8452656 | PubMed |
| 8037888 | Clinically significant drug interactions with the oral anticoagulants. | Drug Saf | 1994 | https://conductscience.org/library/papers/8037888 | PubMed |
| 7408366 | Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole). | Clin Pharmacokinet | 1980 | https://conductscience.org/library/papers/7408366 | PubMed |
| 6661352 | Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6661352 | PubMed |
| 3905334 | Importance of drug enantiomers in clinical pharmacology. | Drugs | 1985 | https://conductscience.org/library/papers/3905334 | PubMed |
| 3744457 | Current antibiotic usage II: Aminoglycosides, tetracyclines, erythromycin, vancomycin and sulphonamides. | Indian J Pediatr | 1986 | https://conductscience.org/library/papers/3744457 | PubMed |
| 2288835 | Lack of effect of co-trimoxazole on the pharmacokinetics and pharmacodynamics of nifedipine. | Br J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2288835 | PubMed |
| 2178847 | Clinical pharmacokinetics 1990. | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2178847 | PubMed |
| 1623906 | A comparison of the relative sensitivities of factor VII and prothrombin time measurements in detecting drug interactions with warfarin. | Eur J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1623906 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/464451
GET https://conductscience.org/api/papers/v1/464451/authors